January 10, 2021
Four Seasons HotelSan Francisco, CA Roland BuelowCEO at TeneoBioSpeaker
Profile
Dr. Buelow is founder and CEO of Teneobio (www.teneobio.com). He has worked in biotechnology for thirty years and is a serial entrepreneur. In 2007 Dr. Buelow founded OMT, which was acquired by Ligand in 2015. He is also a founder of THP, Inc. (2003), which was acquired by Roche in March 2007. Between 1993 and 2003, Dr. Buelow was senior vice president of Research and Development at SangStat Medical Corporation. Dr. Buelow has published more than 100 manuscripts and is an inventor on more than 25 patents.
Agenda Sessions
Different Business Models in Biopharma
2:15pmView Session